<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Mukherjee SD</submitter><funding>NIDDK NIH HHS</funding><pubmed_abstract>Decades of research have made clear that host-associated microbiomes touch all facets of health. However, effective therapies that target the microbiome have been elusive given its inherent complexity. Here, we experimentally examined diet-microbe-host interactions through a complex systems framework, centered on dietary oxalate. Using multiple, independent molecular, animal, and &lt;i>in vitro&lt;/i> experimental models, we found that microbiome composition influenced multiple oxalate-microbe-host interfaces. Importantly, administration of the oxalate-degrading specialist, &lt;i>Oxalobacter formigenes,&lt;/i> was only effective against a poor oxalate-degrading microbiota background and gives critical new insights into why clinical intervention trials with this species exhibit variable outcomes. Data </pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2024.10.28.620613</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11565779</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Complex system modelling reveals oxalate homeostasis is driven by diverse oxalate-degrading bacteria.</pubmed_title><pmcid>PMC11565779</pmcid><funding_grant_id>R01 DK121689</funding_grant_id><pubmed_authors>Dearing D</pubmed_authors><pubmed_authors>Batagello CA</pubmed_authors><pubmed_authors>Agudelo J</pubmed_authors><pubmed_authors>Mukherjee SD</pubmed_authors><pubmed_authors>Zampini A</pubmed_authors><pubmed_authors>Nguyen A</pubmed_authors><pubmed_authors>Monga M</pubmed_authors><pubmed_authors>Adler A</pubmed_authors><pubmed_authors>Orr T</pubmed_authors><pubmed_authors>Miller AW</pubmed_authors><pubmed_authors>Suryavanshi M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Complex system modelling reveals oxalate homeostasis is driven by diverse oxalate-degrading bacteria.</name><description>Decades of research have made clear that host-associated microbiomes touch all facets of health. However, effective therapies that target the microbiome have been elusive given its inherent complexity. Here, we experimentally examined diet-microbe-host interactions through a complex systems framework, centered on dietary oxalate. Using multiple, independent molecular, animal, and &lt;i>in vitro&lt;/i> experimental models, we found that microbiome composition influenced multiple oxalate-microbe-host interfaces. Importantly, administration of the oxalate-degrading specialist, &lt;i>Oxalobacter formigenes,&lt;/i> was only effective against a poor oxalate-degrading microbiota background and gives critical new insights into why clinical intervention trials with this species exhibit variable outcomes. Data </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2025-07-10T03:08:50.898Z</modification><creation>2025-04-06T03:20:55.457Z</creation></dates><accession>S-EPMC11565779</accession><cross_references><pubmed>39553961</pubmed><doi>10.1101/2024.10.28.620613</doi></cross_references></HashMap>